Increasing HIV testing for young children in rural Uganda
Improving HIV testing among Children under five in Rural Uganda
This study is working to help more young children in rural Uganda get tested for HIV by teaming up with trusted local healers, so they can find out about any barriers to testing and make it easier for families to access these important health services.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10839225 on NIH RePORTER |
What this research studies
This research aims to improve HIV testing rates among children aged 18 months to 5 years in rural Uganda by collaborating with traditional healers who are trusted figures in the community. The study will identify barriers to testing and adapt a previously successful program that increased testing among adults. By engaging traditional healers, the project seeks to facilitate access to HIV testing for young children, ensuring that more cases are diagnosed and treated early. The approach will involve interviews and community engagement to tailor the program effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 18 months to 5 years living in rural Uganda who may be at risk for HIV.
Not a fit: Patients outside the age range of 18 months to 5 years or those not residing in rural Uganda may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of HIV in young children, significantly improving their health outcomes.
How similar studies have performed: Previous research has shown success in increasing HIV testing rates through partnerships with traditional healers in similar contexts.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hooft, Anneka M — University of California, San Francisco
- Study coordinator: Hooft, Anneka M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.